Logo image of CURV

TORRID HOLDINGS INC (CURV) Stock Fundamental Analysis

USA - NYSE:CURV - US89142B1070 - Common Stock

1.46 USD
0 (0%)
Last: 10/17/2025, 8:04:38 PM
1.41 USD
-0.05 (-3.42%)
After Hours: 10/17/2025, 8:04:38 PM
Fundamental Rating

3

Overall CURV gets a fundamental rating of 3 out of 10. We evaluated CURV against 120 industry peers in the Specialty Retail industry. There are concerns on the financial health of CURV while its profitability can be described as average. CURV is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

CURV had positive earnings in the past year.
CURV had a positive operating cash flow in the past year.
CURV had positive earnings in 4 of the past 5 years.
In the past 5 years CURV always reported a positive cash flow from operatings.
CURV Yearly Net Income VS EBIT VS OCF VS FCFCURV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M

1.2 Ratios

CURV has a Return On Assets (0.80%) which is in line with its industry peers.
With an excellent Return On Invested Capital value of 12.72%, CURV belongs to the best of the industry, outperforming 80.83% of the companies in the same industry.
CURV had an Average Return On Invested Capital over the past 3 years of 19.24%. This is significantly above the industry average of 12.17%.
The 3 year average ROIC (19.24%) for CURV is well above the current ROIC(12.72%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 0.8%
ROE N/A
ROIC 12.72%
ROA(3y)5.1%
ROA(5y)2.78%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)19.24%
ROIC(5y)15.7%
CURV Yearly ROA, ROE, ROICCURV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 60

1.3 Margins

CURV has a Profit Margin (0.31%) which is comparable to the rest of the industry.
CURV's Profit Margin has declined in the last couple of years.
The Operating Margin of CURV (3.45%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of CURV has declined.
The Gross Margin of CURV (35.83%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of CURV has remained more or less at the same level.
Industry RankSector Rank
OM 3.45%
PM (TTM) 0.31%
GM 35.83%
OM growth 3Y13.99%
OM growth 5Y-6.94%
PM growth 3YN/A
PM growth 5Y-18.22%
GM growth 3Y-3.3%
GM growth 5Y-0.39%
CURV Yearly Profit, Operating, Gross MarginsCURV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CURV is creating value.
Compared to 1 year ago, CURV has more shares outstanding
The number of shares outstanding for CURV has been reduced compared to 5 years ago.
Compared to 1 year ago, CURV has an improved debt to assets ratio.
CURV Yearly Shares OutstandingCURV Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
CURV Yearly Total Debt VS Total AssetsCURV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

CURV has an Altman-Z score of 1.80. This is a bad value and indicates that CURV is not financially healthy and even has some risk of bankruptcy.
CURV has a Altman-Z score (1.80) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 1.8
ROIC/WACC1.22
WACC10.39%
CURV Yearly LT Debt VS Equity VS FCFCURV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M -200M 300M

2.3 Liquidity

CURV has a Current Ratio of 0.83. This is a bad value and indicates that CURV is not financially healthy enough and could expect problems in meeting its short term obligations.
CURV's Current ratio of 0.83 is on the low side compared to the rest of the industry. CURV is outperformed by 82.50% of its industry peers.
A Quick Ratio of 0.26 indicates that CURV may have some problems paying its short term obligations.
CURV has a Quick ratio of 0.26. This is amonst the worse of the industry: CURV underperforms 82.50% of its industry peers.
Industry RankSector Rank
Current Ratio 0.83
Quick Ratio 0.26
CURV Yearly Current Assets VS Current LiabilitesCURV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

1

3. Growth

3.1 Past

The earnings per share for CURV have decreased strongly by -69.23% in the last year.
The earnings per share for CURV have been decreasing by -16.48% on average. This is quite bad
The Revenue has decreased by -5.76% in the past year.
CURV shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.26% yearly.
EPS 1Y (TTM)-69.23%
EPS 3YN/A
EPS 5Y-16.48%
EPS Q2Q%-75%
Revenue 1Y (TTM)-5.76%
Revenue growth 3Y-5.24%
Revenue growth 5Y1.26%
Sales Q2Q%-7.67%

3.2 Future

CURV is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -12.52% yearly.
The Revenue is expected to decrease by -3.48% on average over the next years.
EPS Next Y-54.31%
EPS Next 2Y-18.18%
EPS Next 3Y-12.52%
EPS Next 5YN/A
Revenue Next Year-8.21%
Revenue Next 2Y-4.71%
Revenue Next 3Y-3.48%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CURV Yearly Revenue VS EstimatesCURV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
CURV Yearly EPS VS EstimatesCURV Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 0.2 0.4 0.6 0.8

2

4. Valuation

4.1 Price/Earnings Ratio

CURV is valuated quite expensively with a Price/Earnings ratio of 36.50.
CURV's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 27.40. CURV is valued slightly more expensive when compared to this.
With a Price/Forward Earnings ratio of 13.63, CURV is valued correctly.
Based on the Price/Forward Earnings ratio, CURV is valued a bit cheaper than 69.17% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.94. CURV is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 36.5
Fwd PE 13.63
CURV Price Earnings VS Forward Price EarningsCURV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CURV indicates a rather cheap valuation: CURV is cheaper than 84.17% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.4
CURV Per share dataCURV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8 10

4.3 Compensation for Growth

CURV's earnings are expected to decrease with -12.52% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-18.18%
EPS Next 3Y-12.52%

0

5. Dividend

5.1 Amount

CURV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

TORRID HOLDINGS INC

NYSE:CURV (10/17/2025, 8:04:38 PM)

After market: 1.41 -0.05 (-3.42%)

1.46

0 (0%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)09-04 2025-09-04/amc
Earnings (Next)12-01 2025-12-01/amc
Inst Owners28.2%
Inst Owner Change0%
Ins Owners7.49%
Ins Owner Change-22.4%
Market Cap144.79M
Analysts55
Price Target2.93 (100.68%)
Short Float %5.91%
Short Ratio2.7
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-7.77%
Min EPS beat(2)-38.09%
Max EPS beat(2)22.55%
EPS beat(4)2
Avg EPS beat(4)-23.57%
Min EPS beat(4)-129.71%
Max EPS beat(4)50.98%
EPS beat(8)6
Avg EPS beat(8)6.91%
EPS beat(12)7
Avg EPS beat(12)0.44%
EPS beat(16)10
Avg EPS beat(16)1.25%
Revenue beat(2)1
Avg Revenue beat(2)-1.01%
Min Revenue beat(2)-2.54%
Max Revenue beat(2)0.51%
Revenue beat(4)2
Avg Revenue beat(4)-2.37%
Min Revenue beat(4)-9.52%
Max Revenue beat(4)2.08%
Revenue beat(8)4
Avg Revenue beat(8)0%
Revenue beat(12)5
Avg Revenue beat(12)-0.32%
Revenue beat(16)8
Avg Revenue beat(16)0.5%
PT rev (1m)-2.71%
PT rev (3m)-44.81%
EPS NQ rev (1m)-71.88%
EPS NQ rev (3m)-67.85%
EPS NY rev (1m)-48.28%
EPS NY rev (3m)-43.63%
Revenue NQ rev (1m)-3.06%
Revenue NQ rev (3m)-8.89%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.2%
Valuation
Industry RankSector Rank
PE 36.5
Fwd PE 13.63
P/S 0.14
P/FCF N/A
P/OCF 21.7
P/B N/A
P/tB N/A
EV/EBITDA 5.4
EPS(TTM)0.04
EY2.74%
EPS(NY)0.11
Fwd EY7.34%
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0.07
OCFY4.61%
SpS10.77
BVpS-2.03
TBVpS-2.11
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.8%
ROE N/A
ROCE 19.78%
ROIC 12.72%
ROICexc 14.24%
ROICexgc 14.93%
OM 3.45%
PM (TTM) 0.31%
GM 35.83%
FCFM N/A
ROA(3y)5.1%
ROA(5y)2.78%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)19.24%
ROIC(5y)15.7%
ROICexc(3y)21.41%
ROICexc(5y)18.14%
ROICexgc(3y)22.22%
ROICexgc(5y)18.8%
ROCE(3y)29.27%
ROCE(5y)23.72%
ROICexcg growth 3Y22.64%
ROICexcg growth 5Y12.07%
ROICexc growth 3Y22.04%
ROICexc growth 5Y11.47%
OM growth 3Y13.99%
OM growth 5Y-6.94%
PM growth 3YN/A
PM growth 5Y-18.22%
GM growth 3Y-3.3%
GM growth 5Y-0.39%
F-Score4
Asset Turnover2.58
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 3.76
Cap/Depr 20.81%
Cap/Sales 0.74%
Interest Coverage 1.08
Cash Conversion 8.93%
Profit Quality N/A
Current Ratio 0.83
Quick Ratio 0.26
Altman-Z 1.8
F-Score4
WACC10.39%
ROIC/WACC1.22
Cap/Depr(3y)56.43%
Cap/Depr(5y)50.16%
Cap/Sales(3y)1.79%
Cap/Sales(5y)1.58%
Profit Quality(3y)196.65%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-69.23%
EPS 3YN/A
EPS 5Y-16.48%
EPS Q2Q%-75%
EPS Next Y-54.31%
EPS Next 2Y-18.18%
EPS Next 3Y-12.52%
EPS Next 5YN/A
Revenue 1Y (TTM)-5.76%
Revenue growth 3Y-5.24%
Revenue growth 5Y1.26%
Sales Q2Q%-7.67%
Revenue Next Year-8.21%
Revenue Next 2Y-4.71%
Revenue Next 3Y-3.48%
Revenue Next 5YN/A
EBIT growth 1Y-35.88%
EBIT growth 3Y8.01%
EBIT growth 5Y-5.77%
EBIT Next Year61.91%
EBIT Next 3Y21.64%
EBIT Next 5YN/A
FCF growth 1Y-106.33%
FCF growth 3Y-15.28%
FCF growth 5Y-2.85%
OCF growth 1Y-83.6%
OCF growth 3Y-13.89%
OCF growth 5Y-4.83%